SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vestis
If you suffered losses exceeding $75,000 in Vestis between May 2, 2024 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - June 27, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Vestis Corporation ('Vestis' or the 'Company') (NYSE: VSTS) and reminds investors of the August 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/6455/257027_01cfb16ce43f7823_001full.jpg ]
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Vestis' ability to grow its business; notably that Vestis would be unable to execute on planned strategic initiatives to drive purported improvements to the customer experience and its onboarding efforts in order to drive new customer growth, increased customer retention, and increased revenue from existing customers.
On May 7, 2025, Vestis announced its financial results for the second quarter of fiscal 2025, withdrew its revenue and growth guidance for the full fiscal year 2025, and provided guidance for the third quarter of fiscal 2025 that fell significantly below market expectations. The Company attributed its poor results partially to 'lost business in excess of new business,' but primarily on 'lower adds over stops, which is how we describe volume changes with our existing customers.' The Company attributed its decision to pull full-year guidance and provide disappointing third quarter targets to the 'increasingly uncertain macro environment.'
Following this news, the price of Vestis' common stock declined dramatically. From a closing market price of $8.71 per share on May 6, 2025, Vestis' stock price fell to $5.44 per share on May 7, 2025, a decline of about 37.54% in the span of just a single day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Vestis' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Vestis Corporation class action, go to www.faruqilaw.com/VSTS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/257027
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
16 minutes ago
- USA Today
Nasdaq tops NYSE in 2025 IPO race with $21.3 billion in listings
Nasdaq handily beat the New York Stock Exchange in stock market listings during the first half of 2025, buoyed by blockbuster initial public offerings of big names like CoreWeave CRWV.O and Chime CHYM.O and a jump in proceeds raised via special purpose acquisition companies. IPOs at Nasdaq NDAQ.O, including those of blank-check acquisition companies, raised about $21.3 billion during the first half, compared with $8.7 billion for flotations at the NYSE ICE.N, according to data from Dealogic. Excluding SPAC volumes, traditional IPOs on the Nasdaq raised roughly $9 billion from 79 deals, while 15 IPOs on NYSE raised about $7.8 billion. Last year during the same period, Nasdaq IPOs had raised about $6.1 billion, while shares worth $11.5 billion were sold from IPOs on NYSE. Stock market launches dropped off sharply during the April market selloff that was driven by erratic U.S. trade policy, but Wall Street has since recovered and companies are starting to rush back to seek listings. "We felt this year had an opportunity to be good - and then we had enormous volatility to start the year, so companies across the board had to go pencils down," Nasdaq President Nelson Griggs told Reuters. "Clearly now, with the market rebound we've had after a very strong May, companies are back having those discussions. If the next round (of companies) does well, I think you're going to really see some excitement for the fall," Griggs added. More financial markets: Stocks usually rise by 10% a year. Those days may be over. The Nasdaq Composite .IXIC and S&P 500 .SPX reached record closing highs on Monday, capping their best quarter in more than a year. With its first-half listings performance, Nasdaq maintained its stranglehold at the top of the rankings. The exchange operator has led the IPO rankings ahead of NYSE during the better part of the past decade, including the last six years, according to Dealogic. The market share battle between the two top U.S. exchanges and the improving outlook for stock market listings follows an arid spell for capital markets that lasted for more than two years. Several big names, including medical supply giant Medline and design software maker Figma are gearing up for IPOs later this year. Liquefied natural gas exporter Venture Global's VG.N $1.75 billion share sale, CoreWeave's $1.5 billion raise, and cybersecurity firm SailPoint's SAIL.O $1.38 billion offering ranked as the biggest U.S. IPOs during the first half. "The largest IPO YTD is listed on the NYSE. We anticipate that issuance for the remainder of the year will continue to be active," NYSE Global Head of Capital Markets Michael Harris said. High-profile switches Both exchanges have been beneficiaries of large corporations transferring listings from one venue to the other. This year, Nasdaq has received a boost from high-profile switches including those of Kleenex tissue maker Kimberly-Clark KMB.O and content and technology company Thomson Reuters the parent company of Reuters News. Nasdaq said 10 companies with a combined market value of $271.4 billion have switched from the NYSE this year, the best first-half performance for the exchange operator since it started tracking the data from 2006. NYSE was buoyed by transfers from five companies including financial services firm Virtu VIRT.N, CSW Industrials CSW.N, and building products distributor QXO QXO.N in the first half. Some companies that transferred from NYSE to Nasdaq this year cited the attractiveness of the Nasdaq-100 index .NDX - which includes 100 of the most valuable non-financial companies listed on the Nasdaq, including the likes of Nvidia NVDA.O and Apple AAPL.O - as being a key driver for the decision to switch. The Nasdaq 100 has risen nearly 8% this year, compared to the S&P 500 .SPX, which has climbed about 5.5% year-to-date. "We realized very quickly that Nasdaq had something that was very compelling - if you are in the Nasdaq and you meet the threshold for the market cap, you can be part of the Nasdaq-100, a great index to be a member of," said Juan Pelaez, vice-president of investor relations at chemicals company Linde LIN.O, which switched to Nasdaq in 2023. The rivalry between Nasdaq and NYSE has played a big role in making U.S. capital markets more attractive for investors, compared to other markets like Hong Kong and London, which currently have only one venue for flotations, according to experts. Reporting by Anirban Sen in New York; Editing by Alden Bentley and Jamie Freed
Business Wire
21 minutes ago
- Business Wire
Asbury Automotive Group Schedules Release of Second Quarter 2025 Financial Results
DULUTH, Ga.--(BUSINESS WIRE)--Asbury Automotive Group, Inc. (NYSE: ABG), one of the largest automotive retail and service companies in the U.S., announced that it will release its second quarter financial results before the market opens on Tuesday, July 29, 2025. Asbury will host a conference call later that day at 10:00 a.m. Eastern Time. The conference call will be simulcast live on the internet and can be accessed by logging onto A replay will be available on this site for 30 days. In addition, live audio will be accessible to the public. Participants may enter the conference call five to ten minutes prior to the scheduled start of the call by dialing: About Asbury Automotive Group, Inc Asbury Automotive Group, Inc. (NYSE: ABG), a Fortune 500 company headquartered in Duluth, GA, is one of the largest automotive retailers in the U.S. In late 2020, Asbury embarked on a multi-year plan to increase revenue and profitability strategically through organic operations, acquisitive growth and innovative technologies, with its guest-centric approach as Asbury's constant North Star. As of June 30, 2025, Asbury operated 145 new vehicle dealerships, consisting of 189 franchises and representing 31 domestic and foreign brands of vehicles. Asbury also operates Total Care Auto, Powered by Landcar, a leading provider of service contracts and other vehicle protection products, and 37 collision repair centers. Asbury offers an extensive range of automotive products and services, including new and used vehicles; parts and service, which includes vehicle repair and maintenance services, replacement parts and collision repair services; and finance and insurance products, including arranging vehicle financing through third parties and aftermarket products, such as extended service contracts, guaranteed asset protection debt cancellation, and prepaid maintenance. Asbury is recognized as one of America's Fastest Growing Companies 2024 by the Financial Times and the Company is listed in World's Most Trustworthy Companies 2024 by Newsweek. For additional information, visit
Yahoo
33 minutes ago
- Yahoo
Constellation Brands (NYSE:STZ) Misses Q2 Revenue Estimates
Beer, wine, and spirits company Constellation Brands (NYSE:STZ) missed Wall Street's revenue expectations in Q2 CY2025, with sales falling 5.5% year on year to $2.52 billion. Its non-GAAP profit of $3.22 per share was 2.3% below analysts' consensus estimates. Is now the time to buy Constellation Brands? Find out in our full research report. Revenue: $2.52 billion vs analyst estimates of $2.55 billion (5.5% year-on-year decline, 1.5% miss) Adjusted EPS: $3.22 vs analyst expectations of $3.29 (2.3% miss) Adjusted EBITDA: $829.7 million vs analyst estimates of $950.5 million (33% margin, 12.7% miss) Management reiterated its full-year Adjusted EPS guidance of $12.75 at the midpoint Operating Margin: 28.4%, down from 35.4% in the same quarter last year Free Cash Flow Margin: 17.7%, up from 11.8% in the same quarter last year Organic Revenue fell 4% year on year (6% in the same quarter last year) Market Capitalization: $28.78 billion With a presence in more than 100 countries, Constellation Brands (NYSE:STZ) is a globally renowned producer and marketer of beer, wine, and spirits. Reviewing a company's long-term sales performance reveals insights into its quality. Any business can have short-term success, but a top-tier one grows for years. With $10.06 billion in revenue over the past 12 months, Constellation Brands is one of the larger consumer staples companies and benefits from a well-known brand that influences purchasing decisions. However, its scale is a double-edged sword because there are only a finite number of major retail partners, placing a ceiling on its growth. For Constellation Brands to boost its sales, it likely needs to adjust its prices, launch new offerings, or lean into foreign markets. As you can see below, Constellation Brands's 3.2% annualized revenue growth over the last three years was sluggish. This shows it failed to generate demand in any major way and is a rough starting point for our analysis. This quarter, Constellation Brands missed Wall Street's estimates and reported a rather uninspiring 5.5% year-on-year revenue decline, generating $2.52 billion of revenue. Looking ahead, sell-side analysts expect revenue to decline by 6.6% over the next 12 months, a deceleration versus the last three years. This projection doesn't excite us and implies its products will face some demand challenges. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. When analyzing revenue growth, we care most about organic revenue growth. This metric captures a business's performance excluding one-time events such as mergers, acquisitions, and divestitures as well as foreign currency fluctuations. The demand for Constellation Brands's products has generally risen over the last two years but lagged behind the broader sector. On average, the company's organic sales have grown by 2.8% year on year. In the latest quarter, Constellation Brands's organic sales fell by 4% year on year. This decline was a reversal from its historical levels. We'll keep a close eye on the company to see if this turns into a longer-term trend. The company's revenue and EPS both missed, which is a poor start. However, Constellation Brands did maintain its full-year revenue guidance. Still, this quarter could have been better. The stock remained flat at $165 immediately following the results. Constellation Brands didn't show it's best hand this quarter, but does that create an opportunity to buy the stock right now? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here, it's free. Sign in to access your portfolio
